Table V.
Variables | Cut off value | Total | Overall survival time (months) | P-value |
---|---|---|---|---|
Sex | 0.035 | |||
Male | 228 | 37.0±7.0 | ||
Female | 42 | 21.0±3.3 | ||
Age (years) | 0.345 | |||
<60 | 222 | 44.5±3.2 | ||
≥60 | 48 | 52.9±6.7 | ||
Bile duct invasion | <0.001 | |||
Yes | 107 | 16.6±1.7 | ||
No | 163 | 84.0±21.6 | ||
PVTT | 0.006 | |||
Yes | 35 | 18.0±1.5 | ||
No | 235 | 40.0±6.7 | ||
Presence of hepatitis | 0.041 | |||
Yes | 257 | 44.9±3.1 | ||
No | 13 | 66.5±8.2 | ||
Presence of cirrhosis | 0.534 | |||
Yes | 153 | 37.0±8.6 | ||
No | 117 | 28.0±6.9 | ||
Tumor size (cm) | 0.184 | |||
<5 | 99 | 42.0±8.3 | ||
≥5 | 171 | 25.0±7.9 | ||
Multiple tumor lesions | 0.029 | |||
Yes | 40 | 17.0±1.9 | ||
No | 230 | 37.0±6.9 | ||
AFP (ng/ml) | <0.001 | |||
<20 | 89 | 68.0±21.0 | ||
≥20 | 181 | 24.0±4.1 | ||
PT (sec) | 0.078 | |||
<14 | 249 | 39.0±6.9 | ||
≥14 | 21 | 25.0±4.6 | ||
TBIL (mg/dl) | <0.001 | |||
<2 | 203 | 50.0±10.9 | ||
≥2 | 67 | 13.0±1.7 | ||
ALB (g/l) | <0.001 | |||
<35 | 22 | 8.0±3.3 | ||
≥35 | 248 | 39.0±6.5 | ||
ALT (U/l) | 0.002 | |||
<40 | 99 | 61.7±5.4 | ||
≥40 | 171 | 38.2±3.2 |
TBIL, total bilirubin; PVTT, portal vein tumor thrombosis; ALB, albumin; ALT, alanine transaminase; PT, prothrombin time; AFP, α-fetoprotein.